NCT00578630View on ClinicalTrials.gov

Interindividual Genetic Variability as a Determinant of Chemotherapy Toxicity and Response in Pediatric Bone Marrow Transplantation Patients

CompletedOBSERVATIONAL
Enrollment

128

Participants

Timeline

Start Date

October 14, 2003

Primary Completion Date

November 30, 2018

Study Completion Date

November 30, 2018

Conditions
Neoplasms
Interventions
OTHER

buccal swabs and obtaining peripheral blood

will be the collection of normal cells and assessments of toxicity following chemotherapy at routine clinic visits.

Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

American Cancer Society, Inc.

OTHER

collaborator

Montefiore Medical Center

OTHER

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00578630 - Interindividual Genetic Variability as a Determinant of Chemotherapy Toxicity and Response in Pediatric Bone Marrow Transplantation Patients | Biotech Hunter | Biotech Hunter